Sinopharm BBIBP-CorVi and Myocarditis: A Causal Link?

Abstract

Since the introduction of the SARS-CoV-2 vaccine, several side effects have been reported, including acute myocarditis, which is primarily associated with mRNA vaccines. However, the cardiac side effects of other forms of vaccination against COVID-19 are still unknown. Here, we present a case of a possible connection between myocarditis and attenuated vaccine Sinopharm BBIBP-CorV. An 18-year-old female patient was admitted to the intensive care unit (ICU) for the management of respiratory distress associated with hemodynamic instability one week after receiving an attenuated vaccine Myocarditis has been reported as a complication of SARS-CoV-2 mRNA vaccines. Our case report suggests a possible link between myocarditis and attenuated vaccines. Therefore, more research is warranted to determine this causal link.